David M. Knott’s iShares Biotechnology ETF IBB Stock Holding History

David M. Knott’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$151K	–	150
2021 Q1	$151K	Hold	1,000	–	–	0.06%	95
2020 Q4	$151K	Hold	1,000	–	–	0.07%	74
2020 Q3	$135K	Buy	+1,000	New	+$136K	0.08%	67

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

David M. Knott's IBB Position: Q2 2021 in Review

David M. Knott sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 1,000 shares — an estimated $151K sold.

David M. Knott first reported a position in IBB in Q3 2020 and held it in 3 quarters. The position peaked at $151K in Q1 2021. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

David M. Knott reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
David M. Knott sold 1,000 iShares Biotechnology ETF shares in Q2 2021, an estimated $151K.
David M. Knott first reported a position in iShares Biotechnology ETF in Q3 2020 and held it in 3 quarters.
David M. Knott's iShares Biotechnology ETF position peaked at $151K in Q1 2021.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on David M. Knott's 13F filing for Q2 2021, filed 13 Aug 2021.